Fourth Annual Next-Gen Launch Report
From Science to Scale – What 2024 Taught Us About Launch Excellence
Home / Intelligence / White Papers / Fourth Annual Next-Gen Launch Report
The 2024 cohort of pharmaceutical and biotechnology launches has set a new benchmark, according to analysis by Trinity Life Sciences, with 50% of new launches exceeding their first-year forecasts. Marked by innovative therapies, streamlined regulatory approvals, executional excellence and advanced technology these launches have outperformed prior years across nearly all metrics. 2024 marked a turning point in which commercial execution is on pace with scientific innovation—launches are smarter, faster, and more patient-centric than ever. This whitepaper explores the factors driving these improvements and presents case studies highlighting the strategies and innovations shaping the industry’s future.
Complete the form below to access the white paper.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Related Intelligence
White Papers
Predicting Winners: AI-Powered Portfolio Management
Can artificial intelligence and machine learning (AIML) be used to support portfolio decision-making across the life sciences industry? In this installment of our Industry Impact Series, we find that not only can the latest AIML techniques identify the drivers of success and failure in commercialization, but Trinity Life Sciences’ AI algorithm accurately predicts revenue outcomes for […]
Read More
Webinars
Launch & Learn: Trinity Launch Accelerator
Available On Demand
Today’s launch environment is fraught with greater complexity, lack of standardization and executional inefficiency. Join us for a virtual lunch and learn where experts share how Launch Accelerator enables teams to overcome launch barriers with a simple launch readiness and management process.
Watch Now
Webinars
Trinity Annual Drug Index
Available On Demand
White Paper & On-demand Webinar: This report, the seventh in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the performance of novel drugs approved by the FDA in 2021, scoring each […]
Watch Now